AI can boost efficacy of cancer treatment, but doctors remain key
A new study led by researchers from Moffitt Cancer Center, in collaboration with investigators from the University of ...
Hosted on MSN4d
New study reveals why most life-long smokers never develop lung cancer
Lung cancer remains the leading cause of cancer-related deaths globally, with cigarette smoking as its primary driver.
Dad says NHS let down cancer-hit son, 35, who was treated as 'druggie' before his death
Andrew Shepherd said his son Anthony was treated for a lump in a Birmingham hospital during a spell in prison in 2017 and ...
Armed robbery in Revesby3h
AI Enhances Cancer Treatment, Doctors Still Vital
A new study led by researchers from Moffitt Cancer Center , in collaboration with investigators from the University of Michigan, shows that ...
ophthalmologytimes3d
Tyrosine kinase inhibitor: An alternative treatment for non–small-cell lung cancer metastasis to the choroid
Investigators conducted a retrospective review that spanned 10 years with the goals of describing the clinical ...
Becker's Hospital Review2h
The scope of the 'cancer' label debate
Debate over labeling certain cancers as 'benign' or 'premalignant' instead of 'cancer' due to stigma and fear. Experts weigh in on potential impact ...
The American Journal of Managed Care3h
Atezolizumab Fails to Help in High-Risk Triple-Negative Breast Cancer
Atezolizumab (Tecentriq) plus chemotherapy after surgery did not improve survival in high-risk triple-negative breast cancer, according to a global phase 3 trial.
BioSpace6d
Merck’s Keytruda Combo Fails to Extend Survival in Phase III GI Cancer
The unsuccessful Phase III results are the latest to suggest that the blockbuster cancer drug is finally bumping up against ...
Scientific Research Publishing4d
Solitary Osteolytic Bone Metastatic Lesion from Prostate Carcinoma: A Case Report ()
Patient was not fit for Docetaxel therapy and he was put on monthly Denosumab injection 120 mg/1 syringe, and Abiraterone ...